Co-Diagnostics up 24% on advancement of coronavirus test 
 Nano cap Co-Diagnostics (CODX ) jumps on an 8x surge in volume on the heels of its announcement that it has completed the initial verification of a screening test for the coronavirus responsible for the current outbreak.